Chandra Bhagat Pharma IPO Review, Dates, Allotment, Size, Live Bid Details, GMP & RHP

Last Updated Date: Nov 16, 2022

Let’s have a detailed review of the company and analytics of the Chandra Bhagat Pharma Limited IPO release date, IPO offer price, subscription, Chandra Bhagat Pharma IPO allotment, grey market price and other details like the company’s background, its financial positions, its promoters and other related things. Stock Broker Complaints

Chandra Bhagat Pharma IPO Review & Ratings

IPO Ratings & Review
Criteria	Ratings
Industry Sentiments	7.9/10
Industry Ranking	7.2/10
Company Background	8.2/10
Company Reputation	7.7/10
Competitive Edge	7.2/10
Financial Statements	8.0/10
Popularity Index	7.9/10
Promoters Reputation	8.0/10
Retail Appetite	7.1/10
Top Brokers Review	7.8/10
Overall Ratings	7.5/10
Star Ratings	★★★★☆

Summary of Chandra Bhagat Pharma IPO

Chandra Bhagat Pharma IPO

They are engaged in the business of marketing pharmaceutical critical care & health care products. For which they have obtain necessary approvals from FDA for getting the formulations manufacture from contract manufacturers on Loan license or on principle to principle basis. They also take the necessary Trademark approvals & registrations wherever required.

At present, they have a wide range of products portfolio of pharmaceutical formulation including IV & IM range Injections, few tablets to cater the Domestic & Export Market. They have established presence in major therapeutic categories for formulations such as Anti-cancer (Oncology), Antibiotics, Anesthesia, Hormones, Orthopedic, Cardiac, Cardiovascular, Anti-fungal, Antiviral, Pediatrics, Cardiology, Nephrology, Neurology etc. They are also engaged in promoting and marketing of Active Pharmaceuticals Ingredients (API’s) in India.

From FY 2016-17 to FY 2018-2019, as per the Restated Financial Statements

In the past three (3) years their revenue from operations have increased from Rs.8,978.63 Lakh in F. Y. 2016-17 to Rs.9,705.94 Lakh in F. Y. 2017-18 and further to Rs.10,627.82 Lakh in F. Y. 2018-19.

The Promoters of this company are MR. HEMANT CHANDRAVADAN BHAGAT and Mr. MR. HEMANT CHANDRAVADAN BHAGAT. The lead manager to the issue is BEELINE BROKING LIMITED. The Registrar to this issue is LINK INTIME INDIA PRIVATE LIMITED.

List of Upcoming IPOs

Chandra Bhagat Pharma IPO Dates / Launch Date

The opening and the closing date of Chandra Bhagat Pharma IPO is Jan 31, 2020 – Feb 6, 2020.

Chandra Bhagat Pharma IPO Subscription

Day / Date	NII	RII	Total Subscription
1st Day – Jan 31	1.44x	0.08x	0.76x
2nd Day – Feb 3	1.52x	0.25x	0.88x
3rd Day – Feb 4	1.54x	0.41x	0.98x
4th Day – Feb 5	1.58x	0.55x	1.06x
Shares Offered or Net Issue	950,000	950,000	1,900,000

The shares subscribed by the public will be updated here.

Chandra Bhagat Pharma IPO Allotment Status

Here, you can find the Allotment Status of this IPO. Allotment of Equity Shares pursuant to the Fresh Issue and transfer of the Offered Shares of the Promoter Selling Shareholders pursuant to the Offer for Sale to the successful Bidders. However, the Allotment status is not yet disclosed.

Chandra Bhagat Pharma IPO Listing Date

Find the dates below on basis of allotment, refund, listing and more:

Basis of Allotment Finalization	Feb 11, 2020
Refunds Initiation	Feb 13, 2020
Credit of Shares to Demat Account	Feb 13, 2020
Share Listing Date	Feb 14, 2020

Chandra Bhagat Pharma IPO Price Band / Cash Price

The face value of each share is Rs.10,and the cash price of the IPO is Rs.51.

Chandra Bhagat Pharma IPO Size

This Initial Public Issue of 2000000 Equity Shares of Rs.10 each for cash at a price of Rs.51 per equity share aggregating to Rs.1020.00 lakhs.

Chandra Bhagat Pharma IPO Share Offering

Fresh Issue: The Fresh Issue of 2000000 Equity Shares by their Company of Rs.10 each at a price of Rs.51 per equity share aggregating to Rs.1020.00 lakhs,

Net Issue : The Net Issue of 1900000 Equity Shares of Rs.10 each at Rs.51 per Equity Share aggregating to Rs. 969.00 lakhs.

Chandra Bhagat Pharma Limited – Company Overview

Their Company was incorporated as “Chandra Bhagat Pharma Private Limited” at Mumbai on March 10, 2003, under the provisions of the Companies Act, 1956 vide Certificate of Incorporation issued by Assistant Registrar of Companies, Maharashtra, Mumbai.

Inspirited by their founder Late Shree Chandravadan Bhagat’s sense of personal mission, they are driven to fill the gap in pharma sector especially in critical lifesaving medicines in India. Their promoters have a combined experience of more than 41 years in the Pharmaceutical products, Bulk drugs and vaccines.

Driven by the passion for building an integrated pharmaceutical company, backed by their more than two decades of experience, their Promoters have been the pillars of their Company’s growth since inception and have built a strong value system for their Company. With their enriching experience and progressive thinking, they aim to continue to grow in the pharmaceutical and bulk drugs in India and abroad.

Chandra Bhagat Pharma – Core Business

Ethical marketing of Pharmaceutical formulation & products in Domestic and International market through own distribution network and Sales force under own brand. Major focus in Injection – IV (Intravenous) & IM (Intramuscular), dry syrup, tablets and capsules supply to Hospital and Health care center for critical deceases.
Getting their approved formulations manufacture through Contract Manufacturers, Source & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO, Hospitals & Distributors.
Specialty Chemicals, Intermediates & Active Pharmaceuticals Ingredients (API) – They source, deal in Import, indenting and Supply in API & its intermediate.

Chandra Bhagat Pharma – Market Reach

They operate both in domestic and international markets. Presently, they are supplying Pharmaceutical formulation, Active Pharmaceutical Ingredients (APIs) in the domestic markets. They export Pharmaceutical Formulation to countries like Philippines, Bolivia, DR CONGO. Further, their company is planning for exports in countries located in South East Asia, Middle East, Latin America, and West Africa.

Chandra Bhagat Pharma Distribution and Marketing Network

Their company has established own distribution and marketing network in major states of India. With its own network, company has developed the reputation and goodwill for timely supply of material to their reputed clients. Currently, they have a registered and corporate office located in Mumbai, Maharashtra.

The company is backed by a team of highly creative and experienced professionals who have an affinity for creating innovative approach in sourcing & marketing of formulations. The company’s team has been a major strength as it understands the varied needs of the clients and works accordingly. From processing to finish, the company tries its best to ensure the quality of every single product delivered by the company.

Chandra Bhagat Pharma Limited: Business strategies

Focus on increasing their global sales
Increasing Operational efficiency
Broaden and Deepen presence in existing product portfolio
Increase by targeting unexplored markets
Expand their scope by adding more products

Chandra Bhagat Pharma Ltd – Financial Statements

On the basis of Standalone statement:

Amount (in INR & Lakhs)
	31-July-19	31-Mar-19	Mar-18	31-Mar-17
Total Assets	8,594.26	8,285.52	5,805.76	5,589.60
Total Revenue	3344.50	10671.83	9773.41	9,028.11
Total Expense	3311.51	10583.26	9620.16	8,936.80
Profit After Tax	24.88	62.59	103.38	66.03

Earnings per Equity Share (in Lakhs)

Amount (in INR & Lakhs)
	31-July-19	Mar-19	31-Mar-18	31-Mar-17
Basic & Diluted	0.46	1.17	3.09	1.97

Chandra Bhagat Pharma IPO – Promoters

The Promoters of this company are:

MR. HEMANT CHANDRAVADAN BHAGAT
MR. PRANAV HEMANT BHAGAT

List of Related Parties (Key Managerial Personnel)

Mr. Hemant Chandravadan Bhagat, Chairman cum Managing Director
Mr. Pranav Hemant Bhagat, Whole-Time Director
Prachi Pranav Bhagat, Executive Director & CFO

Interest of Promoters

Their Promoters do not have any other interest in their business.

Interests of Promoter in property of their Company

Their Promoter, Directors or Group Companies do not have any interest in any property acquired by their Company in the preceding three years before filing this Draft Prospectus. Further, they do not have any interest in any property to be acquired by their Company till the date of this Draft Prospectus.

Chandra Bhagat Pharma IPO Offer Details or Issue Details

Particulars	No. Of Equity Shares
Equity Shares Offered	2000000 Equity Shares, aggregating up to Rs. 1020.00 Lakhs
Of which:
Reserved for Market Makers	100000 Equity Shares, aggregating up to Rs.51.00 Lakhs
Net Issue to the Public*	1900000 Equity Shares, aggregating up to Rs.969.00 Lakhs
Of which:
Retail Portion	950000 Equity Shares of Rs.10/- each at an Issue Price of Rs.51/- each aggregating to Rs.484.50 Lakh
Non Retail Portion	950000 Equity Shares of Rs.10/- each at an Issue Price of Rs.51/- each aggregating to Rs.484.50 Lakh
Equity Shares outstanding prior to the Issue	5545056 Equity Shares
Equity Shares outstanding after the Issue	7545056 Equity Shares

Chandra Bhagat Pharma IPO Issue Object

The Issue Proceeds from the Fresh Issue will be utilized towards the following objects:

To Meet Incremental Working Capital Requirements;
Setting up Distribution and Warehousing Centre’s;
General Corporate Purpose;
To meet Public Issue Expenses

Chandra Bhagat Pharma Limited: Competitive Strength

Experienced Promoters and management team
Scalable Business Model
Relationships with multi-national companies
Wide and diverse range of product offerings
Strategic Location of Contract Manufacturing Facilities
Diversified business operations and revenue base
Strong sales, marketing and distribution capabilities

Chandra Bhagat Pharma IPO – Basis of the Offer Price

The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.

Qualitative factors are:

Experienced Promoters and management team
Scalable Business Model
Relationships with multi-national companies
Wide and diverse range of product offerings
Strategic Location of Contract Manufacturing Facilities
Diversified business operations and revenue base
Strong sales, marketing and distribution capabilities

Chandra Bhagat Pharma IPO – Quantitative Factors

	Basic & Diluted EPS	RONW in %	NAV (Rs.)
31-Mar-17	1.97	8.91	–
31-Mar-18	3.09	12.91	–
31-Mar-19	1.17	4.71	198.06

Price to Earnings (P/E) ratio in relation to Price band of Rs.51 to Rs.10 per Equity Share

Particulars	P/E ratio
Highest	–
Average	–
Lowest	–

Chandra Bhagat Pharma Limited: Competitive Peers

	Total Revenue (Rs. in lakhs)	Face Value (Rs.)	P/E	EPS (Basic) (Rs.)	Return on Net Worth (%)	NAV per share (Rs.)
Chandra Bhagat Pharma Limited	10,627.82	10	43.59	1.17	4.71	198.06
Listed Peers
Earum Pharmaceuticals Limited^	5,070.00	10	0.84	53.83	27.95	192.67
Vaishali Pharma Limited^	7,509.10	10	24.12	1.08	3.73	32.47

Chandra Bhagat Pharma IPO Lead Managers

Lead Manager

BEELINE BROKING LIMITED
SEBI Registration Number: INM000012546
Address:807, Phoenix Tower, Opp. New Girish Cold Drinks, Near Vijay Cross Roads, Navrangpura, Ahmedabad – 380 009
Telephone Number:+91 79 4840 5357
Email Id:mb@beelinemb.com
Investors Grievance Id: ig@beelinebroking.com
Website: www.beelinebroking.com
Contact Person: Mrs. Khushbu Shah
CIN:U51900GJ2014PLC080598

Chandra Bhagat Pharma IPO Registrar to Offer

Registrar to the Offer

LINK INTIME INDIA PRIVATE LIMITED
SEBI Registration Number: INR000004058
Address: C-101, 1st Floor, 247 Park, Lal Bahadur Shastri Marg, Vikhroli (West), Mumbai – 400 083, Maharashtra
Tel. Number: +91 22 4918 6200
Email Id: cbpl.ipo@linkintime.co.in
Investors Grievance Id: cbpl.ipo@linkintime.co.in
Website: www.linkintime.co.in
Contact Person: Ms. Shanti Goapalkrishnan
CIN: U67190MH1999PTC118368

CBC IPO – Other Details:

Statutory Auditor – M/s. A Y & Company, Chartered Accountants, Jaipur
Legal Counsel to the Company – Ms. Pooja Sharma
Bankers to the Company – Axis Bank Limited

Chandra Bhagat Pharma IPO Review by Top 10 Stock Brokers

Top Stock Brokers Review	Company Reputation	Competitive Edge	Financial Statement	Popularity Index	Promoters Reputation
Angel Broking	7.5/10	7.4/10	8.5/10	8.1/10	7.1/10
Sharekhan	7.2/10	7.1/10	8.6/10	8.1/10	7.2/10
Kotak Securities	7.3/10	7.5/10	8.4/10	8.1/10	7.3/10
ICICI Direct	7.3/10	7.3/10	8.7/10	8.1/10	7.1/10
IIFL	7.5/10	7.2/10	8.8/10	8.0/10	7.1/10
Edelweiss	7.5/10	7.4/10	8.4/10	8.3/10	7.2/10
Zerodha	7.4/10	7.1/10	8.5/10	8.1/10	7.0/10
5Paisa	7.1/10	7.1/10	8.4/10	8.1/10	7.1/10
Karvy	7.4/10	7.3/10	8.2/10	8.1/10	7.1/10
Motilal Oswal	7.1/10	7.1/10	8.6/10	8.3/10	7.2/10